The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers
Authors:
- 1 July 1990
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 4 (4) , 219-232
Abstract
In this study 26 healthy volunteers received scopolamine 0.7 mg subcutaneously on seven occasions at least a week apart. Cognitive efficiency was measured with a test battery before and 60 min following scopolamine on each occasion. Following this, over the seven occasions, a range of oral and intravenous dose regimens were administered including aniracetam 2 mg intravenously, 100 mg intravenously, 200 mg intravenously, 1500 mg per os and piracetam 2400 mg per os. On each session the test battery was then performed again at 120 and 200 min following scopolamine. The seven treatments were administered double- blind and the order was counterbalanced between volunteers over visits using a Latin Square design. At 60 min, scopolamine produced marked and significant decrements in all of the measures of memory and information processing. Aniracetam 1500 mg was able to sig nificantly antagonize decrements on both memory and information processing tasks. The other active treatments also produced significant effects, but for two these were equal to, and for two slightly above, the number which may have occurred by chance, and thus were questionable. Overall, the findings demonstrate that aniracetam 1500 mg can antagonize cognitive decrements produced by cholinergic blockade in healthy volunteers, and suggest that the drug possesses nootropic properties.Keywords
This publication has 31 references indexed in Scilit:
- An investigation of the range of cognitive impairments induced by scopolamine 0·6 mg s.cHuman Psychopharmacology: Clinical and Experimental, 1988
- A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderlyHuman Psychopharmacology: Clinical and Experimental, 1987
- Alzheimer's disease: a correlative study.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Smoking, nicotine and human performancePharmacology & Therapeutics, 1983
- Effects of Scopolamine on Stimulus Sensitivity and Response Bias in a Visual Vigilance TaskNeuropsychobiology, 1983
- Effects of Smoking on Rapid Information Processing PerformanceNeuropsychobiology, 1983
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- Physostigmine: Improvement of Long-Term Memory Processes in Normal HumansScience, 1978
- Human Serial Learning: Enhancement with Arecholine and Choline Impairment with ScopolamineScience, 1978
- Choline: Selective enhancement of serial learning and encoding of low imagery words in manLife Sciences, 1978